Business Context and Reporting Period
This Form 8-K is a current report filed by Inmune Bio, Inc. (INMB), an emerging growth company incorporated in Nevada. The report covers events occurring on March 14, 2022, and March 15, 2022. The company is headquartered in Boca Raton, Florida, and its common stock trades on The NASDAQ Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate events rather than financial performance data.
Material Changes
There are no material financial changes reported in this filing. The document discloses upcoming corporate activities and conference participation rather than changes in financial position or operations.
Guidance, Outlook, and Management Commentary
Management announced the following upcoming events:
- Conference Participation: The company will participate in the 32nd Annual Oppenheimer Health Care Conference and the 2022 Maxim Group Virtual Growth Conference.
- Data Presentations: The company announced nine data presentations scheduled for the AD/PD TM 2022 International Conference on Alzheimer's and Parkinson's Diseases.
No specific financial guidance, risk factors, or contingencies were detailed in this specific filing text.
Important Facts for Investors to Verify
- Verify the specific dates and agenda for the Oppenheimer Health Care Conference and Maxim Group Virtual Growth Conference.
- Review the content of the nine data presentations at the AD/PD TM 2022 conference, as referenced in Exhibit 99.2.
- Confirm the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.